Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan CARLSBAD, Calif. — Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical Co., Ltd., a member of the Roche Group, and has applied to the Ministry of Health, Labour and Welfare (MHLW) to expand the use of the Oncomine Dx […]

HORIBA is thrilled to announce a strategic collaboration with Qnami, leader and pioneer in scanning NV magnetometry based on diamond quantum sensing. The multi-part agreement will allow materials science customers to benefit from solutions combining HORIBA’s advances in AFM instrumentation with Qnami’s game-changing innovation in quantum sensing. Palaiseau, Saclay Campus, France – HORIBA, a global […]

– Long-term partnership to facilitate cancer research through development of custom antibodies – Agreement to enable global access to resulting reagents and potential diagnostics London, UK and Cambridge, UK – Today, Cancer Research UK, the world’s largest independent funder of cancer research and Abcam plc, a global innovator in life science reagents and tools, are […]

UPPER HEYFORD, England and BURLINGAME, California — 2BScientific, Ltd, leading distributor of reagents to the European research market, and Vector Laboratories, Inc., a Maravai LifeSciences company and pioneer in the development and manufacture of reagents for immunohistochemistry, immunofluorescence, glycobiology and bioconjugation, announced today that they have established an innovative model for the supply of Vector Laboratories products in the United Kingdom and Ireland. […]

TOKYO, JAPAN Hitachi, Ltd (TSE: 6501, “Hitachi”) and ThinkCyte, Inc. (“ThinkCyte”) today announced that they have entered into a collaboration focused on developing an artificial intelligence (AI)-driven cell analysis and sorting system. Hitachi provides a broad range of solutions such as automated cell culture technologies to pharmaceutical companies in the value chain*1 of the regenerative […]

SOUTH EASTON, Massachusetts — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmetics, nutraceuticals, and food & beverage industries, today announced that the Company has entered into a worldwide co-marketing agreement with German-based Leica Microsystems CMS […]

SAN FRANCISCO and MONTGOMERY, Texas — Biocare Medical, LLC, a leading provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, announces a collaborative partnership with Bethyl Laboratories to develop targeted antibodies for cancer research and oncology diagnostics. Bethyl Laboratories has 45 years of experience in antibody development and has been dedicated to supporting scientific discovery to advanced laboratories around the world. […]

Maennedorf, Switzerland – Tecan is pleased to announce that it has entered into a collaboration with leading smart lab provider Labforward. Labforward introduces Well Plate Templates and the Tecan Connector App* add-ons for their Labfolder electronic lab notebook software that offers connectivity with Tecan microplate readers. Laboratories increasingly require an easy-to-use solution that integrates lab […]

Partnership targets accelerating the commercialization of enzymatic DNA synthesis; Codexis invests cash and protein engineering for equity stake in Molecular Assemblies REDWOOD CITY, Calif. and SAN DIEGO  – Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announce […]

First-of-its-kind test allows for significant increase in testing capacity NASHVILLE, Tenn. – PathGroup, one of the largest private providers of pathology, clinical and molecular laboratory services in the United States, today announced the company has been selected as an early access partner for the launch of Illumina’s new sequencing-based COVID-19 test, COVIDSeq. COVIDSeq accommodates more […]